It is one of the oldest jokes in the gerontologists' book – if you want to live to a grand age, choose your parents carefully. Jeanne Calment, who had the longest confirmed human life span in history, attributed her longevity – she died in 1998 aged 122 years, five months and 14 days – to a diet rich in olive oil, regular glasses of port and her ability to "keep smiling". But destiny undoubtedly played the most important part.
We spend millions of pounds each year on anti-ageing tonics, potions, vitamins and creams, trying to stave off the ravages of the years. But our genetic inheritance trumps all other factors in determining how well we age and how long we live. By unravelling the genetic determinants of longevity, scientists believe they will be able to manipulate them to add not only years to life, but also life to years. An elixir of youth remains a distant dream but medicines to help us live longer and better are moving closer.
At a conference this week, Turning Back the Clock, organised by the Royal Society, researchers described the progress that has been made in the science of ageing. At least 10 gene mutations have been identified that extend the lifespan of mice by up to half, and in humans several genetic variants have been linked with longevity. They include a family of genes dubbed the sirtuins, which one Italian study found occurred more commonly in centenarian men than in the general population. A subsidiary of drug giant GlaxoSmithKline is now looking at sirtuins, and their association with a range of age-related diseases including type 2 diabetes and cancers.
Other gene variants affect the production of growth hormone and insulin-like growth factor (IGF), both of which increase metabolism – organisms with higher metabolism tend to die sooner. A possible of way of slowing ageing would be to slow metabolism by blocking receptors for growth hormone and IGF.
A small Massachusetts biotech company, Proteostasis, is investigating this pathway involving IGF as a potential target for anti-ageing drugs. Another key drug target is an enzyme called cholesteryl ester transfer protein (CETP), which affects levels of "good" cholesterol, that help protect against heart disease. Drugs that inhibit the enzyme are being developed by two other major pharmaceutical companies, Merck and Roche.
Also promising, but still far from yielding concrete results, are telomeres, which are present in every cell. Activating telomerase, an enzyme which lengthens the telomeres, may extend cell lifespan.
Developments such as these herald a new era of longevity research and drugs based on them will "probably be available for testing from 2012", Professor Nir Barzilai of the Albert Einstein College of Medicine in New York told the conference.
He said: "I'm seeing 100-year-olds who are not only 100 years old but in great shape. They're driving and painting, and they say life is beautiful. I have this bias that makes me believe we have the ability as a species to get to 100 if we prevent some of these age-related diseases."
Centenarians tended to have genes that delayed the onset of conditions such as Alzheimer's and heart disease. "When they eventually die they die of the same things that people die of in their seventies and eighties. It's just that they do so 30 years later," Professor Barzilai said. "The cost of treating 100-year-olds in their last two years of life is a third of what it costs to treat somebody aged 70 to 80. People who die between 70 and 80 are sick in the last few years of their life. Centenarians are dying healthy, all of a sudden."
drive from www.independent.co.uk
Now it's his turn. After the elder George Bush, Bill Clinton and George Bush the younger, Barack Obama has became the fourth consecutive American president to seek international diplomacy's hitherto impossible prize: Israeli-Palestinian peace.
To sceptics of alternative medicine, it will come as a surprise. Applying magnets to the brains of Alzheimer's disease sufferers helps them understand what is said to them. The finding by Italian scientsts, who conducted a randomised controlled trial of the treatment, suggests that magnets may alter "cortical activity" in the brain, readjusting unhealthy patterns caused by disease or damage. The study was small, involving just 10 patients, and the results are preliminary.
Defender Paul Konchesky has been reunited with former manager Roy Hodgson after finally completing his move to Liverpool from Fulham.
Desperate not to miss an important cricket match between his village and its local rival, it was the liberal politician and banker Sir John Lubbock who introduced the August bank holiday in 1871. 139 years later, up and down the country, the end-of-summer weekend break is the preserve of a far more eclectic range of hobbyists and sports people.
In 2007, my sister Leah was diagnosed with bowel cancer. She's had major surgery twice, two courses of chemotherapy, radiotherapy, a temporary (now reversed) ileostomy and additional drug treatment. Three years on, she has an inoperable tumour in her liver and has just started a third course of chemotherapy. The cumulative side effects from the various cocktails of drugs have resulted in many other physical problems. An appeal to Hertfordshire Primary Care Trust for funding a new treatment was declined the first time round and again more recently following a review. Among their reasons they say that they do not feel there is any "individual exceptionality" in this case. We are still unsure what this actually means. While not a cure, this treatment would certainly give Leah a longer life. An appeal takes place on 11 August, with new evidence and the support of various professionals.
The New York skyline is a sculpture created by the friction between civic regulation and the capitalist love of profit. The former element might not be immediately obvious to a casual observer. Manhattan, after all, is a kind of symbol of capitalist aspiration in itself, a thrusting desire to climb a little higher up the ladder than the fellow next door. But restraint is expressed there too – and sometimes in literally concrete form.
Supermarkets are shunning seasonal British food in favour of fruit and vegetables air-freighted from thousands of miles away, according to research for the Independent.
If Pakistan presumed they were back in the Test series, England's youngest bowler begged to differ yesterday. Ignoring the third Test defeat, or perhaps using the evidence of the tourists' shaky second innings, Steve Finn said: "We have bowled them out for 72 and 80 in this series so obviously there is a batting collapse waiting to happen."
Broadcaster Andy Kershaw is to return to BBC Radio 3 after three years off-air as a result of personal problems, it was announced today.